Physician profile
Patrick Dennis
NPI 1245750231
$26,211.80
in general payments reported to CMS, 2019-2025
13 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2021: $239 · 2022: $3,569 · 2023: $729 · 2024: $4,183 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $17K · Travel and Lodging: $2,831 · Food and Beverage: $2,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $17,000.00 |
| Travel and Lodging | $2,830.92 |
| Food and Beverage | $2,350.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $24,665.51 | 2022-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $287.41 | 2023-2024 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Innovation Technologies INC | $214.73 | 2019-2021 | |
| Davol INC. | $157.34 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $154.85 | 2022-2025 | Megadyne, Echelon Endopath |
| Teleflex LLC | $131.16 | 2023 | Titan Sgs Standard Gastric Stapler |
| Integra Lifesciences Corporation | $118.54 | 2021 | |
| Tela Bio, INC. | $109.16 | 2024 | Ovitex 2s |
| Tei Biosciences INC | $107.08 | 2019 | |
| Lilly USA, LLC | $87.03 | 2024 | Omvoh |
| Novo Nordisk INC | $85.74 | 2024 | Wegovy |
| Atricure, INC. | $70.29 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $22.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.